Taken together, these observations suggested that RBM47-dependent suppression of tumor progression was partially mediated by its ability to increase the production of the Wnt antagonist DKK1, a secreted protein that can inhibit tumor phenotypes in metastatic cancer cells. The gene discussed is DKK1; the disease is metastatic malignant neoplasm.